NASDAQ:ATRI - Atrion Stock Price, Forecast & News

Atrion trades on the NASDAQ under the ticker symbol "ATRI."

Atrion announced a quarterly dividend on Tuesday, November 12th. Investors of record on Monday, December 2nd will be given a dividend of $1.55 per share on Monday, December 16th. This represents a $6.20 dividend on an annualized basis and a yield of 0.86%. The ex-dividend date of this dividend is Friday, November 29th. View Atrion's Dividend History.

Atrion Co. (NASDAQ:ATRI) released its quarterly earnings data on Friday, November, 1st. The medical instruments supplier reported $5.15 EPS for the quarter. The medical instruments supplier had revenue of $38.88 million for the quarter. Atrion had a return on equity of 16.45% and a net margin of 23.43%. View Atrion's Earnings History.

Atrion is scheduled to release their next quarterly earnings announcement on Tuesday, February 25th 2020. View Earnings Estimates for Atrion.

Press coverage about ATRI stock has trended extremely negative this week, according to InfoTrie. InfoTrie identifies negative and positive press coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Atrion earned a news sentiment score of -4.5 on InfoTrie's scale. They also assigned news headlines about the medical instruments supplier a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an impact on the company's share price in the next few days. View News Stories for Atrion.

Atrion saw a decrease in short interest in December. As of December 31st, there was short interest totalling 101,500 shares, a decrease of 7.6% from the December 15th total of 109,800 shares. Based on an average daily volume of 10,500 shares, the days-to-cover ratio is presently 9.7 days. Approximately 7.1% of the shares of the stock are short sold. View Atrion's Current Options Chain.

Some companies that are related to Atrion include Align Technology (ALGN), Cooper Companies (COO), DENTSPLY SIRONA (XRAY), West Pharmaceutical Services (WST), Haemonetics (HAE), ICU Medical (ICUI), Neogen (NEOG), Quidel (QDEL), Merit Medical Systems (MMSI), STAAR Surgical (STAA), Antares Pharma (ATRS), Anika Therapeutics (ANIK), Cerus (CERS), OraSure Technologies (OSUR) and Meridian Bioscience (VIVO).

Based on aggregate information from My MarketBeat watchlists, some companies that other Atrion investors own include ABM Industries (ABM), International Paper (IP), AT&T (T), Westrock (WRK), Exxon Mobil (XOM), Gilead Sciences (GILD), Methanex (MEOH), Pattern Energy Group (PEGI), Walgreens Boots Alliance (WBA) and AbbVie (ABBV).

Atrion's stock is owned by many different of institutional and retail investors. Top institutional shareholders include Boston Trust Walden Corp (1.01%), Pennsylvania Trust Co (0.56%), Hudson Valley Investment Advisors Inc. ADV (0.05%) and Nisa Investment Advisors LLC (0.02%). Company insiders that own Atrion stock include Emile A Battat, Jeffery Strickland, John P Stupp Jr and Ronald Nicholas Spaulding. View Institutional Ownership Trends for Atrion.

ATRI stock was sold by a variety of institutional investors in the last quarter, including Nisa Investment Advisors LLC and Pennsylvania Trust Co. Company insiders that have sold Atrion company stock in the last year include John P Stupp Jr and Ronald Nicholas Spaulding. View Insider Buying and Selling for Atrion.

ATRI stock was bought by a variety of institutional investors in the last quarter, including Boston Trust Walden Corp and Hudson Valley Investment Advisors Inc. ADV. View Insider Buying and Selling for Atrion.

Shares of ATRI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of ATRI stock can currently be purchased for approximately $720.03.

Atrion has a market capitalization of $1.33 billion and generates $152.45 million in revenue each year. Atrion employs 570 workers across the globe.View Additional Information About Atrion.

The official website for Atrion is http://www.atrioncorp.com/.

Atrion's mailing address is ONE ALLENTOWN PARKWAY, ALLEN TX, 75002. The medical instruments supplier can be reached via phone at 972-390-9800 or via email at [email protected]